Target Name: IDS
NCBI ID: G3423
Other Name(s): Idursulfase | ID2S | alpha-L-iduronate sulfate sulfatase | L-iduronate-2-sulfate 2-sulfohydrolase | Iduronate 2-sulfatase (isoform a) | IDS variant 1 | iduronate 2-sulfatase 42 kDa chain | MPS2 | IDS_HUMAN | Iduronate 2-sulfatase 14 kDa chain | Iduronate 2-sulfatase 42 kDa chain | iduronate 2-sulfatase | Alpha-L-iduronate sulfate sulfatase | Iduronate 2-sulfatase | iduronate 2-sulfatase 14 kDa chain | Iduronate 2-sulfatase, transcript variant 1 | idursulfase | SIDS

IDS: A Drug Target for Urea Cycle Enzyme

IDS (Idursulfase) is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

Idursulfase is a protein that is expressed in various tissues of the body, including muscle, heart, brain, and liver. It is a key enzyme in the urea cycle, a process that is responsible for the production of proteins from amino acids. The urea cycle is a critical pathway for the regulation of protein synthesis and is involved in the production of proteins that are essential for various cellular functions. Therefore, alterations in the urea cycle have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and chronic diseases.

The urea cycle is also a target for many drugs that are used to treat various diseases, including cancer, neurodegenerative diseases, and chronic diseases. Many of these drugs work by inhibiting the activity of the urea cycle enzyme, either by inhibiting the synthesis of urea or by inhibiting the activity of the enzyme itself. Therefore, IDS is a drug target that may be useful for the development of new treatments for various diseases.

The urea cycle is a critical pathway

Protein Name: Iduronate 2-sulfatase

Functions: Lysosomal enzyme involved in the degradation pathway of dermatan sulfate and heparan sulfate

More Common Targets

IDSP1 | IDUA | IER2 | IER3 | IER3-AS1 | IER3IP1 | IER5 | IER5L | IER5L-AS1 | IFFO1 | IFFO2 | IFI16 | IFI27 | IFI27L1 | IFI27L2 | IFI30 | IFI35 | IFI44 | IFI44L | IFI6 | IFIH1 | IFIT1 | IFIT1B | IFIT2 | IFIT3 | IFIT5 | IFITM1 | IFITM10 | IFITM2 | IFITM3 | IFITM3P2 | IFITM3P7 | IFITM4P | IFITM5 | IFITM8P | IFITM9P | IFNA1 | IFNA10 | IFNA12P | IFNA13 | IFNA14 | IFNA16 | IFNA17 | IFNA2 | IFNA21 | IFNA22P | IFNA4 | IFNA5 | IFNA6 | IFNA7 | IFNA8 | IFNAR1 | IFNAR2 | IFNB1 | IFNE | IFNG | IFNG-AS1 | IFNGR1 | IFNGR2 | IFNK | IFNL1 | IFNL2 | IFNL3 | IFNL4 | IFNLR1 | IFNW1 | IFNWP15 | IFNWP19 | IFRD1 | IFRD2 | IFT122 | IFT122P3 | IFT140 | IFT172 | IFT20 | IFT22 | IFT27 | IFT43 | IFT46 | IFT52 | IFT57 | IFT74 | IFT80 | IFT81 | IFT88 | IFTAP | IGBP1 | IGBP1P1 | IGDCC3 | IGDCC4 | IgE Receptors | IGF1 | IGF1R | IGF2 | IGF2-AS | IGF2BP1 | IGF2BP2 | IGF2BP2-AS1 | IGF2BP3 | IGF2R